This announcement is a separate document:
大参林医药集团股份有限公司关于召开2024年第四次临时股东大会的通知
Notice of Dashenlin Pharmaceutical Group Co., Ltd. on convening the 4th Extraordinary General Meeting of Shareholders in 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.